undamentalytics Newsletter

Bausch Health Companies Inc. income statement

In fiscal 2025, Bausch Health Companies Inc. reported revenue of $10.27bn, up 6.7% on the year before, operating income of $1.81bn (a 17.7% margin) and net income of $157m, or $0.42 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Bausch Health Companies Inc.: income statement, annual
Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue0.81.22.43.55.88.210.49.78.78.48.68.08.48.18.89.610.311.1
Research and development0.00.10.10.10.20.20.30.40.40.40.50.50.50.50.60.60.60.6
Selling, general and administrative0.20.30.60.81.32.02.72.82.62.52.62.42.62.62.93.33.43.5
Operating income0.2−0.10.30.1−0.42.01.5−0.60.1−2.4−0.20.70.50.51.01.51.81.2
Interest expense————————1.81.71.61.51.41.51.31.41.61.6
Income before tax0.2−0.2−0.0−0.4−1.31.1−0.2−2.4−1.7−4.2−1.8−0.9−1.0−0.1−0.40.20.4−0.4
Income tax−0.0−0.0−0.2−0.3−0.50.20.1−0.0−4.1−0.0−0.1−0.4−0.10.10.20.20.20.5
Net income0.2−0.20.2−0.1−0.90.9−0.3−2.42.4−4.1−1.8−0.6−0.9−0.2−0.6−0.00.2−0.8
Diluted EPS$1.11−$1.06$0.49−$0.38−$2.70$2.58−$0.85−$6.94$6.83−$11.81−$5.08−$1.58−$2.64−$0.62−$1.62−$0.13$0.42−$2.22
Diluted shares (average)159m196m326m305m321m342m343m347m352m351m352m355m359m362m365m368m375m378m
EBITDA0.30.10.91.11.63.64.02.33.00.41.92.52.01.82.22.83.02.4

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: BHC vs ZTSBHC vs HLNBHC vs VTRSBHC vs UPC

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Bausch Health Companies Inc.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Bausch Health Companies Inc.